AstraZeneca gets global online STARMAP license from Nanoform Finland Ruchika Sharma26 Oct 2023 2:30 PM ISTHelsinki: Nanoform Finland Plc., an innovative nanoparticle medicine-enabling company has announced that it has granted AstraZeneca Plc a global...
AstraZeneca self-administered nasal flu vaccine accepted for review by USFDA Ruchika Sharma25 Oct 2023 12:30 PM ISTCambridge: AstraZeneca’s Supplemental Biologics License Application (sBLA) for the approval of a self- or caregiver-administered option for...
AstraZeneca-Daiichi Sankyo Enhertu approved in EU for lung cancer Ruchika Sharma24 Oct 2023 1:30 PM ISTCambridge: AstraZeneca and Daiichi Sankyo’s (trastuzumab deruxtecan) has been approved in the European Union (EU) as monotherapy for the...
AstraZeneca Soliris approved in China for the treatment of adults with neuromyelitis optica spectrum disorder Ruchika Sharma22 Oct 2023 4:00 PM ISTCambridge: AstraZeneca has announced that Soliris (eculizumab) has been approved in China for the treatment of adult patients with neuromyelitis...
AstraZeneca gets USFDA priority review for Tagrisso plus chemotherapy for EGFR-mutated advanced lung cancer Ruchika Sharma17 Oct 2023 2:24 PM ISTCambridge: AstraZeneca’s supplemental New Drug Application (sNDA) for Tagrisso (osimertinib) in combination with chemotherapy has been accepted and...
AstraZeneca Forxiga meets primary endpoint for type 2 diabetes Ruchika Sharma8 Oct 2023 10:00 AM ISTCambridge: AstraZeneca has announced positive results from the T2NOW Phase III trial, one of the largest paediatric type 2 diabetes studies performed...
AstraZeneca settles Nexium, Prilosec product liability litigations for USD 425 million Ruchika Sharma4 Oct 2023 1:30 PM ISTAstraZeneca has entered into settlement agreements in the product liability litigations related to Nexium and Prilosec. The agreements effectively...
AstraZeneca rare disease unit acquires Pfizer portfolio for USD 1 billion Ruchika Sharma22 Sept 2023 2:25 PM ISTAstraZeneca's Rare-Disease Unit
AstraZeneca Enhertu recommended for nod in EU by CHMP for HER2-mutant advanced non-small cell lung cancer Ruchika Sharma16 Sept 2023 1:30 PM ISTCambridge: AstraZeneca and Daiichi Sankyo’s (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for...
AstraZeneca seeks to calm CEO speculation after shares drop Ruchika Sharma12 Sept 2023 4:30 PM ISTLondon: AstraZeneca appeared to play down speculation about the future of its CEO after its shares fell more than 4% on Monday following a...
AstraZeneca declares positive results from trial of Tagrisso plus chemotherapy to treat EGFR-mutated advanced lung cancer Ruchika Sharma12 Sept 2023 1:30 PM ISTCambridge: AstraZeneca has announced positive results from FLAURA2 phase III trial of Tagrisso (osimertinib) in combination with chemotherapy for...
AstraZeneca Calquence approved in China for chronic lymphocytic leukaemia Ruchika Sharma5 Sept 2023 11:55 AM ISTCambridge: AstraZeneca’s Calquence (acalabrutinib), a next generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in...
